JP2020516322A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516322A5
JP2020516322A5 JP2020506311A JP2020506311A JP2020516322A5 JP 2020516322 A5 JP2020516322 A5 JP 2020516322A5 JP 2020506311 A JP2020506311 A JP 2020506311A JP 2020506311 A JP2020506311 A JP 2020506311A JP 2020516322 A5 JP2020516322 A5 JP 2020516322A5
Authority
JP
Japan
Prior art keywords
htcbs
nhs ester
pegylation
batch
retention time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020506311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020516322A (ja
JP7146897B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/027854 external-priority patent/WO2018195006A1/en
Publication of JP2020516322A publication Critical patent/JP2020516322A/ja
Publication of JP2020516322A5 publication Critical patent/JP2020516322A5/ja
Application granted granted Critical
Publication of JP7146897B2 publication Critical patent/JP7146897B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020506311A 2017-04-17 2018-04-17 ホモシスチン尿症の治療のための酵素補充療法の最適化 Active JP7146897B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762486246P 2017-04-17 2017-04-17
US62/486,246 2017-04-17
PCT/US2018/027854 WO2018195006A1 (en) 2017-04-17 2018-04-17 Optimization of enzyme replacement therapy for treatment of homocystinuria

Publications (3)

Publication Number Publication Date
JP2020516322A JP2020516322A (ja) 2020-06-11
JP2020516322A5 true JP2020516322A5 (https=) 2021-05-27
JP7146897B2 JP7146897B2 (ja) 2022-10-04

Family

ID=63856394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020506311A Active JP7146897B2 (ja) 2017-04-17 2018-04-17 ホモシスチン尿症の治療のための酵素補充療法の最適化

Country Status (9)

Country Link
US (2) US11324811B2 (https=)
EP (1) EP3612214A4 (https=)
JP (1) JP7146897B2 (https=)
CN (2) CN118064414A (https=)
AU (1) AU2018254410B2 (https=)
CA (1) CA3059592A1 (https=)
IL (1) IL269544B2 (https=)
MX (1) MX2019012347A (https=)
WO (1) WO2018195006A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
FI3998067T3 (fi) * 2015-11-09 2024-10-31 Univ Colorado Regents Koostumukset ja menetelmät homokystinurian hoitoon
IL269544B2 (en) 2017-04-17 2025-01-01 Univ Colorado Regents Streamlining enzyme replacement therapy for the treatment of high homocysteine
ES3058596T3 (en) 2019-06-26 2026-03-11 Travere Therapeutics Switzerland Gmbh Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria
CA3152379A1 (en) * 2019-09-03 2021-03-11 Travere Therapeutics Switzerland Gmbh Cystathionine beta-synthase enzyme therapy for treatment of elevated homocysteine levels
CN114965761B (zh) * 2022-05-17 2024-07-02 深圳赛保尔生物药业有限公司 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法
WO2025193499A1 (en) * 2024-03-12 2025-09-18 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods to potentiate enzyme therapies for treating homocystinuria and homocysteine remethylation disorders

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576559A (en) 1978-12-01 1980-06-09 Chiyou Lsi Gijutsu Kenkyu Kumiai Electron beam fine adjusting device
JPS57209206A (en) 1981-06-08 1982-12-22 Kanebo Ltd Skin type pack agent
US5656425A (en) 1993-08-17 1997-08-12 Regents Of The University Of Colorado Screening for mutations by expressing cDNA segments
US5523225A (en) 1993-09-13 1996-06-04 Regents Of The University Of Colorado DNA sequence encoding human cystathionine β-synthase
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5730990A (en) 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates
US5635375A (en) 1995-01-09 1997-06-03 Regents Of The University Of Colorado Method of increasing the yield and heme saturation of cystathione β-synthase
CA2217696A1 (en) 1995-04-25 1996-10-31 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US5705151A (en) 1995-05-18 1998-01-06 National Jewish Center For Immunology & Respiratory Medicine Gene therapy for T cell regulation
US6153655A (en) 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
EE05214B1 (et) * 1998-04-28 2009-10-15 Applied Research Systems ARS Holding N.V. Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
US6174696B1 (en) 1999-11-12 2001-01-16 Genzyme Corporation Method for the determination of homocysteine
WO2001002600A2 (en) 1999-07-06 2001-01-11 General Atomics Detection of analytes using attenuated enzymes
US20030091543A1 (en) 2001-10-26 2003-05-15 Klein Matthew B. Therapeutic cell preparation grafts and methods of use thereof
AU2003251550A1 (en) 2002-06-17 2003-12-31 The Regents Of The University Of Colorado HUMAN CYSTATHIONINE Beta-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
EP1396537A1 (en) 2002-09-04 2004-03-10 Avidis SA Treatment of elevated plasma homocysteine
CN1863551A (zh) 2003-07-31 2006-11-15 抗癌公司 用于提高在体内的效力的PLP和PEG-rMETase的用途
CN1552905A (zh) 2003-12-18 2004-12-08 中国农业科学院茶叶研究所 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片
US8500720B2 (en) 2005-05-09 2013-08-06 Medtronic, Inc Method and apparatus for treatment of cardiac disorders
US20070010492A1 (en) 2005-07-11 2007-01-11 Generale Robert J Composition and method for reducing homocysteine caused by drugs containing methyl compounds
EP1878739A1 (en) 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. One step IMAC (MCAC) purification of proteins
JP5074146B2 (ja) 2007-03-30 2012-11-14 オリンパス株式会社 カプセル型医療装置
CN101322840A (zh) 2008-05-28 2008-12-17 中国人民解放军军事医学科学院卫生学环境医学研究所 一种人胱硫醚β-合成酶重组蛋白及应用
JP2011084559A (ja) * 2009-09-16 2011-04-28 Institute Of Physical & Chemical Research 改変融合タンパク質
CA2788689C (en) 2010-02-04 2019-07-02 The Board Of Regents Of The University Of Texas System Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
EA201370008A1 (ru) 2010-07-01 2013-06-28 Айсис Инновэйшн Лимитид Лечение когнитивных нарушений
US9034318B2 (en) 2011-08-30 2015-05-19 The Regents Of The University Of Colorado, A Body Corporate Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
WO2015033279A1 (en) 2013-09-04 2015-03-12 Mahesh Kandula Compositions and methods for the treatment of homocystinuria
US11123436B2 (en) * 2015-07-24 2021-09-21 Hanmi Pharm. Co., Ltd. Method of preparing physiologically active polypeptide conjugate
FI3998067T3 (fi) 2015-11-09 2024-10-31 Univ Colorado Regents Koostumukset ja menetelmät homokystinurian hoitoon
IL269544B2 (en) 2017-04-17 2025-01-01 Univ Colorado Regents Streamlining enzyme replacement therapy for the treatment of high homocysteine
ES3058596T3 (en) 2019-06-26 2026-03-11 Travere Therapeutics Switzerland Gmbh Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria
CA3152379A1 (en) 2019-09-03 2021-03-11 Travere Therapeutics Switzerland Gmbh Cystathionine beta-synthase enzyme therapy for treatment of elevated homocysteine levels

Similar Documents

Publication Publication Date Title
JP2020516322A5 (https=)
IL288541B (en) Vaccine against rsv
MX2023008626A (es) Proteinas klotho recombinantes terapeuticas y composiciones y metodos que involucran a las mismas.
MX2021013743A (es) Subunidad s1 modificada de la proteina de espicula de coronavirus.
CY1123997T1 (el) Νεα μεταλλακτικη παραλλαγη αλβουμινης ανθρωπινου ορου
EA201992765A1 (ru) Белки на основе антител с привитым цитокином и способы их применения в лечении рака
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
DK548079A (da) Rekombinations-dna-molekyler og fremgangsmaade til fremstilling deraf
EA200501801A1 (ru) Новые пептиды, которые связываются с рецептором эритропоэтина
CY1113062T1 (el) Πεπτιδια που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης ι ή ιι και σχετικο αντικαρκινικο εμβολιο
CR20230026A (es) Proteínas de fusión gdf15 y usos de estas (divisional 2018-0532)
RU2018115781A (ru) Условно активные полипептиды
JP2017036323A5 (https=)
MX383614B (es) Proteinas de union triespecificas y metodos de uso.
EA201691146A1 (ru) Иммуногенное соединение
WO2007021494A3 (en) Albumin fusion proteins
ATE461215T1 (de) Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
MX2019012347A (es) Optimizacion de terapia de reemplazo enzimatico para el tratamiento de la homocistinuria.
EA201270419A1 (ru) Пролекарства гуанфацина
FI3712264T3 (fi) Kystationiini-beta-syntaasientsyymi homokystinurian hoitoon
PH12019550241A1 (en) Mic-1 compounds and uses thereof
EP4470648A3 (en) Charged depth filtration of antigen-binding proteins
WO2017145097A3 (en) Amino acid and peptide conjugates and conjugation process
JP2012514466A5 (https=)
EA202192925A1 (ru) Твердые формы ингибитора glyt1